Folate Analog Metabolic Inhibitor [EPC]

327344 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 58927
1 RHEUMATOID ARTHRITIS 30898
2 ARTHRALGIA 28069
3 PAIN 27525
4 FATIGUE 21920
5 OFF LABEL USE 20070
6 NAUSEA 18522
7 JOINT SWELLING 17367
8 HEADACHE 15735
9 DRUG INTOLERANCE 15219
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3132 0.9294
1 SWOLLEN JOINT COUNT INCREASED 692 0.9227
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 257 0.8741
3 RHEUMATOID FACTOR POSITIVE 2526 0.8225
4 PEMPHIGUS 5418 0.7693
5 RHEUMATIC FEVER 817 0.7607
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1432 0.7325
7 C-REACTIVE PROTEIN ABNORMAL 2407 0.6879
8 SYNOVITIS 8306 0.6874
9 HAND DEFORMITY 5145 0.6478
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]